Free Trial
NASDAQ:HURA

TuHURA Biosciences (HURA) Stock Price, News & Analysis

TuHURA Biosciences logo
$2.30 -0.13 (-5.35%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$2.35 +0.05 (+2.17%)
As of 08/8/2025 07:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About TuHURA Biosciences Stock (NASDAQ:HURA)

Key Stats

Today's Range
$2.29
$2.46
50-Day Range
$2.22
$3.12
52-Week Range
$1.80
$8.63
Volume
134,145 shs
Average Volume
208,240 shs
Market Capitalization
$100.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.67
Consensus Rating
Buy

Company Overview

TuHURA Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
25th Percentile Overall Score

HURA MarketRank™: 

TuHURA Biosciences scored higher than 25% of companies evaluated by MarketBeat, and ranked 824th out of 925 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    TuHURA Biosciences has received a consensus rating of Buy. The company's average rating score is 3.40, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    TuHURA Biosciences has only been the subject of 2 research reports in the past 90 days.

  • Read more about TuHURA Biosciences' stock forecast and price target.
  • Short Interest

    There is no current short interest data available for HURA.
  • Dividend Yield

    TuHURA Biosciences does not currently pay a dividend.

  • Dividend Growth

    TuHURA Biosciences does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for HURA.
  • Search Interest

    7 people have searched for HURA on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added TuHURA Biosciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, TuHURA Biosciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.20% of the stock of TuHURA Biosciences is held by insiders.

  • Percentage Held by Institutions

    Only 0.62% of the stock of TuHURA Biosciences is held by institutions.

  • Read more about TuHURA Biosciences' insider trading history.
Receive HURA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TuHURA Biosciences and its competitors with MarketBeat's FREE daily newsletter.

HURA Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
TuHURA Biosciences Completes Acquisition of Kineta
See More Headlines

HURA Stock Analysis - Frequently Asked Questions

TuHURA Biosciences' stock was trading at $4.09 on January 1st, 2025. Since then, HURA shares have decreased by 43.8% and is now trading at $2.30.

TuHURA Biosciences, Inc. (NASDAQ:HURA) posted its quarterly earnings data on Thursday, May, 15th. The company reported ($0.15) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by $0.02.

Top institutional shareholders of TuHURA Biosciences include Geode Capital Management LLC (1.33%), Suncoast Equity Management (0.24%) and Intech Investment Management LLC (0.03%).

Shares of HURA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/15/2025
Today
8/09/2025
Next Earnings (Estimated)
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HURA
Previous Symbol
NASDAQ:HURA
CIK
1498382
Web
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$15.00
Low Price Target
$11.00
Potential Upside/Downside
+450.7%
Consensus Rating
Buy
Rating Score (0-4)
3.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$21.68 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
291.69%
Return on Assets
122.09%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.00
Quick Ratio
3.00

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.34 per share
Price / Book
6.76

Miscellaneous

Outstanding Shares
43,680,000
Free Float
43,593,000
Market Cap
$100.46 million
Optionable
N/A
Beta
0.04
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:HURA) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners